BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines earnings (loss) per ordinary share — Diluted ($/sh) ($)
Form 10-Q / 10-K (DB)
Latest, FY2025
0.19
Period ended Dec 31, 2025
Change on a year earlier
-140.4%
-0.47 in FY2024
History
12 years
Since FY2014
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Earnings (loss) per ordinary share — Diluted ($/sh) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0.19 | -140.4% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | -0.47 | -27.7% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | -0.65 | -56.4% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | -1.49 | +23.1% | Form 10-K (filed 2023-02-27) ↗ |
| FY2021 | Dec 31, 2021 | -1.21 | -19.3% | Form 10-K (filed 2023-02-27) ↗ |
| FY2020 | Dec 31, 2020 | -1.50 | +23.0% | Form 10-K (filed 2023-02-27) ↗ |
| FY2019 | Dec 31, 2019 | -1.22 | +31.2% | Form 10-K (filed 2020-03-02) ↗ |
| FY2018 | Dec 31, 2018 | -0.93 | +447.1% | Form 10-K (filed 2019-02-28) ↗ |
| FY2017 | Dec 31, 2017 | -0.17 | -43.3% | Form 10-K (filed 2018-02-28) ↗ |
| FY2016 | Dec 31, 2016 | -0.30 | -42.3% | Form 10-K (filed 2017-03-22) ↗ |
| FY2015 | Dec 31, 2015 | -0.52 | +188.9% | Form 10-K (filed 2017-03-22) ↗ |
| FY2014 | Dec 31, 2014 | -0.18 | – | Form 10-K (filed 2017-03-22) ↗ |
Cite this data
StockData. (2026). BeOne Medicines Earnings (loss) per ordinary share — Diluted ($/sh) ($), annual FY2014–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/fs_eps_diluted
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.